GI CELL - Crunchbase Company Profile & Funding

Q: Where is GI CELL's headquarters?

GI CELL is located in Seongnam, Kyonggi-do, South Korea.

Q: Who invested in GI CELL?

GI CELL is funded by Dayli Partners.

Q: When was the last funding round for GI CELL?

GI CELL closed its last funding round on obfuscated from a Series B round.

Overview

GI CELL

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About GI CELL

CB Rank

1070589

GI CELL is a biotechnology company that develops cell-based medicines.

Founded

obfuscation

Private

Series B

Seongnam, Kyonggi-do, South Korea

51-100

gi-cell.com/kr

Biotechnology

Pharmaceutical

Therapeutics

Funding Rounds

Series B

OBF

obfuscation

Details

Legal Name

GI CELL Inc.

Operating Status

Active

Company Type

For Profit

Contact Email

business@gi-cell.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Allogeneic NK Cell Therapy

A cell therapy using natural killer (NK) cells derived from donors to treat diseases by enhancing immune response.

NK Cell Mass Culture Platform

A technology platform for mass culturing natural killer cells to produce high-purity and high-efficiency immune cells for therapy.

Research & Development

GI CELL is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - GI CELL	1	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - GI CELL	1	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - GI CELL	1	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - GI CELL	1	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - GI CELL	1	obfuscated obfuscation	—	Series B

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - GI CELL	1	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - GI CELL	1	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - GI CELL	1	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - GI CELL	1	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - GI CELL	1	obfuscated obfuscation	—	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Dayli Partners	—	Series B - GI CELL	—
Dayli Partners	—	Series B - GI CELL	—
Dayli Partners	—	Series B - GI CELL	—
Dayli Partners	—	Series B - GI CELL	—
Dayli Partners	—	Series B - GI CELL	—